According to Bliss GVS Pharma's latest financial reports the company has $20.55 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $8.33 M | -53.2% |
2022-03-31 | $17.8 M | 68.12% |
2021-03-31 | $10.59 M | 99.77% |
2020-03-31 | $5.3 M | -57.63% |
2019-03-31 | $12.51 M | 49.7% |
2018-03-31 | $8.35 M | -21.43% |
2017-03-31 | $10.63 M | 189.34% |
2016-03-31 | $3.67 M | -59.89% |
2015-03-31 | $9.16 M | -31.76% |
2014-03-31 | $13.43 M | 44.79% |
2013-03-31 | $9.27 M | -19.76% |
2012-03-31 | $11.56 M | 186.79% |
2011-03-31 | $4.03 M | 17.87% |
2010-03-31 | $3.42 M | 153.6% |
2009-03-31 | $1.34 M | -10.37% |
2008-03-31 | $1.5 M | 57.5% |
2007-03-31 | $0.95 M |